Literature DB >> 26380197

Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Maurizio Salvadori1, Giuseppina Rosso1.   

Abstract

Immunoglobulin A (IgA) nephropathy is one of the most common glomerulonephritis and its frequency is probably underestimated because in most patients the disease has an indolent course and the kidney biopsy is essential for the diagnosis. In the last years its pathogenesis has been better identified even if still now several questions remain to be answered. The genetic wide association studies have allowed to identifying the relevance of genetics and several putative genes have been identified. The genetics has also allowed explaining why some ancestral groups are affected with higher frequency. To date is clear that IgA nephropathy is related to auto antibodies against immunoglobulin A1 (IgA1) with poor O-glycosylation. The role of mucosal infections is confirmed, but which are the pathogens involved and which is the role of Toll-like receptor polymorphism is less clear. Similarly to date whether the disease is due to the circulating immunocomplexes deposition on the mesangium or whether the antigen is already present on the mesangial cell as a "lanthanic" deposition remains to be clarified. Finally also the link between the mesangial and the podocyte injury and the tubulointerstitial scarring, as well as the mechanisms involved need to be better clarified.

Entities:  

Keywords:  Auto antibodies; Complement in renal diseases; Genome-wide association studies; Immunoglobulin A; Immunoglobulin A galactosylation; Mesangial linked growth factors

Year:  2015        PMID: 26380197      PMCID: PMC4561843          DOI: 10.5527/wjn.v4.i4.455

Source DB:  PubMed          Journal:  World J Nephrol        ISSN: 2220-6124


  118 in total

Review 1.  Structure and function relationships in IgA.

Authors:  J M Woof; M W Russell
Journal:  Mucosal Immunol       Date:  2011-09-21       Impact factor: 7.313

Review 2.  Primary IgA nephropathy: new insights into pathogenesis.

Authors:  Jonathan Barratt; John Feehally
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

3.  Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy.

Authors:  A W van den Wall Bake; M R Daha; J J Haaijman; J Radl; A van der Ark; L A van Es
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

4.  Immunological studies of IgA nephropathy: familial and racial aspects.

Authors:  B A Julian; R J Wyatt; F B Waldo; W J Koopman; S Jackson; R E Schrohenloher; J H Galla; J Mestecky; C Czerkinsky
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

5.  Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians.

Authors:  Wanling Yang; Huayang Tang; Yan Zhang; Xianfa Tang; Jing Zhang; Liangdan Sun; Jing Yang; Yong Cui; Lu Zhang; Nattiya Hirankarn; Hui Cheng; Hai-Feng Pan; Jinping Gao; Tsz Leung Lee; Yujun Sheng; Chak Sing Lau; Yang Li; Tak Mao Chan; Xianyong Yin; Dingge Ying; Qianjin Lu; Alexander Moon Ho Leung; Xianbo Zuo; Xiang Chen; Kwok Lung Tong; Fusheng Zhou; Qingchun Diao; Niko Kei Chiu Tse; Hongfu Xie; Chi Chiu Mok; Fei Hao; Sik Nin Wong; Bingjun Shi; Ka Wing Lee; Yan Hui; Marco Hok Kung Ho; Bo Liang; Pamela Pui Wah Lee; Hongzhou Cui; Qing Guo; Brian Hon-Yin Chung; Xiongming Pu; Qiji Liu; Xiaoguang Zhang; Change Zhang; Chun Yin Chong; Hong Fang; Raymond Woon Sing Wong; Yonghu Sun; Mo Yin Mok; Xiang-Pei Li; Yingyos Avihingsanon; Zhifang Zhai; Pornpimol Rianthavorn; Thavatchai Deekajorndej; Kanya Suphapeetiporn; Fei Gao; Vorasuk Shotelersuk; Xiaojing Kang; Shirley King Yee Ying; Lijuan Zhang; Wilfred Hing Sang Wong; Dingxian Zhu; Samuel Ka Shun Fung; Fanqin Zeng; Wai Ming Lai; Chun-Ming Wong; Irene Oi Lin Ng; Maria-Mercè Garcia-Barceló; Stacey S Cherny; Nan Shen; Paul Kwong-Hang Tam; Pak Chung Sham; Dong-Qing Ye; Sen Yang; Xuejun Zhang; Yu Lung Lau
Journal:  Am J Hum Genet       Date:  2012-12-27       Impact factor: 11.025

6.  HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.

Authors:  Yukinori Okada; Keiko Yamazaki; Junji Umeno; Atsushi Takahashi; Natsuhiko Kumasaka; Kyota Ashikawa; Tomomi Aoi; Masakazu Takazoe; Toshiyuki Matsui; Atsushi Hirano; Takayuki Matsumoto; Naoyuki Kamatani; Yusuke Nakamura; Kazuhiko Yamamoto; Michiaki Kubo
Journal:  Gastroenterology       Date:  2011-07-19       Impact factor: 22.682

7.  Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.

Authors:  Loretta Y Y Chan; Joseph C K Leung; Anita W L Tsang; Sydney C W Tang; Kar Neng Lai
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

Review 8.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

9.  BMP-7 protects mesangial cells from injury by polymeric IgA.

Authors:  Wai Long Chan; Joseph C K Leung; Loretta Y Y Chan; K Y Tam; Sydney C W Tang; Kar Neng Lai
Journal:  Kidney Int       Date:  2008-05-21       Impact factor: 10.612

10.  Effect of aggregated immunoglobulin A1 from immunoglobulin A nephropathy patients on nephrin expression in podocytes.

Authors:  Cheng Wang; Zengchun Ye; Hui Peng; Hua Tang; Xun Liu; Zhujiang Chen; Xueqing Yu; Tanqi Lou
Journal:  Nephrology (Carlton)       Date:  2009-04       Impact factor: 2.506

View more
  6 in total

Review 1.  IgA nephropathy: clearance kinetics of IgA-containing immune complexes.

Authors:  Ann Chen; Sung-Sen Yang; Tsai-Jung Lin; Shuk-Man Ka
Journal:  Semin Immunopathol       Date:  2018-09-14       Impact factor: 9.623

Review 2.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

3.  Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2016-01-06

4.  Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.

Authors:  Yuhan Cao; Yuwei Wang; Yinhua Liu; Xinjian Zhu; Guifa Zhang; Sufen Wang; Xiaomei Chen; Daoqin Liu; Cong Fu
Journal:  Dis Markers       Date:  2019-08-14       Impact factor: 3.434

5.  Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli.

Authors:  Flavia Teodora Ioana Paunas; Kenneth Finne; Sabine Leh; Tarig Al-Hadi Osman; Hans-Peter Marti; Frode Berven; Bjørn Egil Vikse
Journal:  BMC Nephrol       Date:  2019-11-14       Impact factor: 2.388

6.  Rituximab use in adult glomerulopathies and its rationale.

Authors:  Joana Eugénio Santos; David Fiel; Ricardo Santos; Rita Vicente; Rute Aguiar; Iolanda Santos; Manuel Amoedo; Carlos Pires
Journal:  J Bras Nefrol       Date:  2019-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.